Announced
Completed
Synopsis
Acquisition by Sienna Biopharmaceuticals of Creabilis, a pharmaceutical company focusing on the development of novel topical treatments for common inflammatory skin conditions.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Bidder Team (3)
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite